From: Severe varicella-zoster virus pneumonia: a multicenter cohort study
No steroid use (n = 60) | Steroids use (n = 10) | p | |
---|---|---|---|
Demographics | |||
Age, years | 43 (34–56) | 48 (35.5–60.75) | 0.60 |
Male gender | 38 (63%) | 5 (50%) | 0.49 |
Co-morbidities | 55 (92%) | 9 (90%) | 1.00 |
Underlying immunosuppression | 33 (55%) | 7 (70%) | 0.50 |
Year of ICU admission | 2009 (2006–2012) | 2010 (2008–2012) | 0.48 |
Time (days) from dyspnea onset to ICU admission | 2 (1–3) | 2 (1–3.25) | 0.79 |
Parameters at ICU admission | |||
Temperature, °C | 39.1 (38.25–39.7) | 39.4 (38.85–40.8) | 0.22 |
Respiratory rate, breaths/min | 30 (26.5–38.5) | 35 (32–35) | 0.34 |
Oxygen flow, L/min | 10 (5–15) | 8.5 (1.5–15) | 0.55 |
Hemoptysis | 6 (10%) | 0 (0%) | 0.58 |
PaO2:FiO2 ratio, mmHg | 105 (75.5–174.5) | 86 (80.5–210) | 1.00 |
SOFA score at day 1 | 5 (4–9) | 7 (5–7.75) | 0.55 |
ICU management | |||
Invasive mechanical ventilation | 36 (60%) | 9 (90%) | 0.08 |
Time (days) from ICU admission to intubation | 1 (1–2) | 1 (1–1) | 0.30 |
ARDS criteria according to the Berlin definition | 31 (52%) | 7 (70%) | 0.33 |
Length of invasive mechanical ventilation, days | 13.5 (7–17.25) | 28 (13–53) | 0.06 |
Bacterial superinfection | 26 (43%) | 8 (80%) | 0.04 |
Outcome data | |||
ICU length of stay, days | 10 (4–17) | 32 (10.75–69.5) | 0.01 |
Hospital length of stay, days | 16.5 (10–32.25) | 40.5 (21.25–74) | 0.02 |
ICU mortality | 12 (20%) | 2 (20%) | 1.00 |
Hospital mortality | 15 (25%) | 6 (60%) | 0.06 |